FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to pharmaceutical compositions and pharmaceutical kits for treating bacterial infections, and a new method for treating the diseases associated with bacterial infections, including tuberculosis. A pharmaceutical composition containing Rifalazil as rifamycin and Cycloferon as an interferon inducer in pharmacologically effective doses. The invention also concerns a pharmaceutical kit for treating the diseases caused by bacterial infections. The kit comprises rifamycin in pharmaceutically effective doses in the form of tablets, capsules or injections. Cycloferon is presented in the form of tablets, capsules or injections; instructions for administering the ingredients of the same pharmaceutical kit are also provided.
EFFECT: preparing the pharmaceutical compositions and pharmaceutical kits for treating bacterial infections, and presenting the new method of treating the diseases associated with bacterial infections, including tuberculosis.
4 cl, 2 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING HIGH-BIOAVAILABILITY RIFABUTIN COMPOSITION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MYCOBACTERIOSIS | 2013 |
|
RU2520603C1 |
| ANTITUBERCULOSIS REMEDY | 2017 |
|
RU2756208C2 |
| DERIVATIVES OF 5-OXO-5H-[1]-BENZOPYRANO-[5,6-B]-4-OXO-4H- -[1,2]-PYRIMIDO-1,4,5,6- TETRAHYDRO-1,3-THIAZINE | 1997 |
|
RU2169732C1 |
| SANFETRINEM OR ITS SALT OR COMPLEX ESTER FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTION | 2018 |
|
RU2757272C2 |
| PREPARATIONS, CONTAINING HUMAN ANTIBODIES APPLIED IN TREATMENT OF MICROBACTERIAL INFECTIONS | 2003 |
|
RU2350352C2 |
| METHOD OF TOXOPLASMOSIS SEVERITY DECREASE, PHARMACEUTICAL COMPOSITION, USE OF RIFAMPYCIN DERIVATIVES FOR PREPARING DRUGS FOR TREATMENT OF PATIENTS WITH TOXOPLASMOSIS | 1994 |
|
RU2121838C1 |
| RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
| ANTIBACTERIAL COMPOUNDS AGAINST DRUG RESISTANT BACTERIA | 2014 |
|
RU2672064C2 |
| INACTIVATED MYCOBACTERIA FOR ORAL USE IN THE PREVENTION OF TUBERCULOSIS | 2013 |
|
RU2657753C2 |
| AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
